Hambleton Julie
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Hambleton Julie. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| 0001496323 | Disposition | 2,000 | — | — | Aug 14, 2025 | |
| 0001773427 | Disposition | 14,155 | — | — | Jul 1, 2025 | |
| 0001773427 | Award / Grant | 10,060 | — | — | May 14, 2025 | |
| 0001773427 | Option Exercise | 13,774 | $32.27 | $444,487 | Feb 10, 2025 | |
| 0001496323 | Option Exercise | 15,132 | $1.39 | $21,033 | Jul 25, 2024 | |
| 0001773427 | Sale | 2,946 | $39.41 | $116,102 | Jun 3, 2024 | |
| 0001773427 | Award / Grant | 4,095 | — | — | May 16, 2024 | |
| 0001773427 | Sale | 2,418 | $29.31 | $70,872 | Jul 19, 2023 | |
| 0001773427 | Sale | 2,400 | $26.92 | $64,608 | Jun 20, 2023 | |
| 0001773427 | Award / Grant | 4,648 | — | — | May 24, 2023 | |
| 0001773427 | Sale | 1,106 | $31.50 | $34,839 | Mar 15, 2023 | |
| 0001773427 | Award / Grant | 4,818 | — | — | May 19, 2022 | |
| 0001496323 | Sale | 1,000 | $80.00 | $80,000 | Aug 9, 2021 | |
| ERAS | Purchase | 6,000 | $16.00 | $96,000 | Jul 20, 2021 | |
| 0001496323 | Sale | 2,000 | $80.00 | $160,000 | Jun 1, 2021 | |
| 0001773427 | Award / Grant | 1,106 | — | — | May 20, 2021 | |
| 0001496323 | Purchase | 5,000 | $18.31 | $91,550 | Sep 18, 2019 | |
| 0001175505 | EVP & Chief Medical Officer | Sale | 3,400 | $35.23 | $119,782 | Nov 11, 2015 |
| 0001175505 | EVP & Chief Medical Officer | Award / Grant | 75,000 | — | — | Aug 20, 2015 |
| 0001175505 | SVP & Chief Medical Officer | Award / Grant | 7,980 | — | — | Apr 30, 2015 |
| 0001175505 | EVP & Chief Medical Officer | Purchase | 64 | $13.70 | $877 | Aug 22, 2014 |